1.Vector analysis outcomes after Femtosecond Laser In-Situ Keratomileusis (FS-LASIK) versus Small Incision Lenticule Extraction (SMILE) for moderate myopic astigmatism
John Arvin B. delos Reyes ; Kathrina Therese O. Mendoza ; Reginald Robert G. Tan
Philippine Journal of Ophthalmology 2024;49(1):39-47
Objectives:
To compare the vector analysis, visual, and refractive outcomes of femtosecond-assisted laser insitu keratomileusis (LASIK) and small incision lenticule extraction (SMILE) among myopic patients with
moderate myopic astigmatism.
Methods:
This was a single-center, retrospective, cohort study that compared eyes that underwent
femtosecond LASIK or SMILE for the correction of myopia and astigmatism of 0.75 to 3.0 diopters. Vector
analysis and standard graphs for reporting visual and refractive outcomes were utilized for analysis.
Results:
There were 82 femtosecond LASIK-treated eyes and 80 SMILE-treated eyes with similar preoperative
characteristics except for slightly higher mean preoperative sphere refraction in the SMILE group (-4.2±2.4 D
vs -4.9±1.6 D, p=0.03). At 3 months, femtosecond LASIK group had better mean uncorrected distance visual
acuity (UDVA) (LogMAR 0.006±0.06 vs 0.06±0.09, p=0.00) and had more eyes achieving postoperative
UDVA of 20/20 or better (88% versus 56%). Although there were similar postoperative spherical equivalents,
residual astigmatism was higher in the SMILE group (0.11±0.22 D vs 0.32±0.30 D, p=0.00). Vector analyses
showed significantly better outcomes for femtosecond LASIK than for SMILE in terms of difference vector
(DV), index of success (IOS), torque, and flattening index (FI). A trend for undercorrection for higher
astigmatism was seen in both groups that was greater in the SMILE group. Both groups showed high safety
with the majority of eyes showing postoperative corrected distance VA (CDVA) within 1 line of preoperative
CDVA (98.8% versus 91.2%).
Conclusion
Although femtosecond LASIK and SMILE have similar predictability at 3 months, femtosecond
LASIK has relatively better efficacy and superior astigmatic outcomes than SMILE for the correction of
moderate myopic astigmatism.
Astigmatism